CN121127247A - Nmn冷冻干燥制剂的制造方法 - Google Patents

Nmn冷冻干燥制剂的制造方法

Info

Publication number
CN121127247A
CN121127247A CN202480028593.4A CN202480028593A CN121127247A CN 121127247 A CN121127247 A CN 121127247A CN 202480028593 A CN202480028593 A CN 202480028593A CN 121127247 A CN121127247 A CN 121127247A
Authority
CN
China
Prior art keywords
nmn
freeze
treatment
dried
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480028593.4A
Other languages
English (en)
Chinese (zh)
Inventor
堤严
伊藤文人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xide Medical Pharmaceutical Co ltd
Original Assignee
Xide Medical Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xide Medical Pharmaceutical Co ltd filed Critical Xide Medical Pharmaceutical Co ltd
Publication of CN121127247A publication Critical patent/CN121127247A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
CN202480028593.4A 2023-04-28 2024-04-26 Nmn冷冻干燥制剂的制造方法 Pending CN121127247A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-074847 2023-04-28
JP2023074847 2023-04-28
PCT/JP2024/016422 WO2024225432A1 (ja) 2023-04-28 2024-04-26 Ｎｍｎ凍結乾燥製剤の製造方法

Publications (1)

Publication Number Publication Date
CN121127247A true CN121127247A (zh) 2025-12-12

Family

ID=93256836

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480028593.4A Pending CN121127247A (zh) 2023-04-28 2024-04-26 Nmn冷冻干燥制剂的制造方法

Country Status (3)

Country Link
JP (1) JPWO2024225432A1 (https=)
CN (1) CN121127247A (https=)
WO (1) WO2024225432A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407278B2 (en) * 1998-11-16 2002-06-18 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and methods for the preparation and use of the same
CN112438918A (zh) * 2019-08-30 2021-03-05 广东丸美生物技术股份有限公司 一种牛油果提取物及其制备方法和在抗衰老化妆品中的应用
WO2021222565A1 (en) * 2020-04-30 2021-11-04 Oncour Pharma, Inc. Negatively charged particles for the treatment of cytokine storm syndrome (css) and acute respiratory distress syndrome (ards)
EP4253396A4 (en) * 2020-11-27 2024-09-11 Mirailab Bioscience Inc. HIGH PURITY BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) AND PROCESS FOR ITS PRODUCTION
CN114835768A (zh) * 2022-05-19 2022-08-02 浙江省农业科学院 从果蔬中提取β-烟酰胺单核苷酸的方法及其纯化方法
CN115769894A (zh) * 2022-12-13 2023-03-10 福迈香港基因工程有限公司 一种含高活性nmn提取物的制备方法

Also Published As

Publication number Publication date
WO2024225432A1 (ja) 2024-10-31
JPWO2024225432A1 (https=) 2024-10-31

Similar Documents

Publication Publication Date Title
RU2214246C2 (ru) Содержащие эпотилон композиции
EP3218061B1 (en) Carmustine pharmaceutical composition
CN102018714A (zh) 制剂
KR101703980B1 (ko) 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
CN1058388C (zh) 稳定的冻干聚血卟啉醚/酯组合物
US20190133953A1 (en) Preparation Method of Azacitidine for Injection
CN121127247A (zh) Nmn冷冻干燥制剂的制造方法
EP3990041B1 (en) Method of reconstituting liposomal annamycin
JP3726255B2 (ja) 安定な凍結乾燥済みチオテパ組成物
JP2023523872A5 (https=)
KR20090024674A (ko) 이온화 방사선에 의해 멸균된 양성자 펌프 억제제를 최종 용기내에 포함하는 비경구 제제
US7012072B2 (en) Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
WO2002002125A1 (en) Injectable composition
CN115252563B (zh) 一种柔红霉素阿糖胞苷脂质体冻干品的制备方法
CN113456598A (zh) 一种舒更葡糖钠冻干粉针剂及其制备方法
US20250195437A1 (en) Continuous spin freeze-drying of nucleic acid containing compositions
CN116421569B (zh) 一种注射用帕瑞昔布钠药物组合物及其制备方法
KR20180041814A (ko) 유기용매 유리 동결건조 시클로포스파미드의 제조방법
CN106924195B (zh) 一种注射用紫杉醇脂质体组合物的冻干工艺
ES2324376T3 (es) Formulaciones farmaceuticas para administracion parenteral que comprenden epotilona.
EP0619735A1 (en) Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)
CN106310244A (zh) 一种注射用门冬酰胺酶的冻干工艺
CN118986903A (zh) 一种注射用盐酸兰地洛尔冻干粉针及其制备方法
CN117379596A (zh) 一种可以快速复溶的微球冻干粉及其制备方法
CN113797170A (zh) 一种注射用氟尿嘧啶冻干剂及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination